Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome

Abstract Transcription factors (TFs) play important roles in many biochemical processes. Many human genetic disorders have been associated with mutations in the genes encoding these transcription factors, and so those mutations became targets for medications and drug design. In parallel, since many...

Full description

Bibliographic Details
Main Authors: Atlal El-Assaad, Zaher Dawy, Athar Khalil, Georges Nemer
Format: Article
Language:English
Published: Nature Portfolio 2021-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-01832-z
_version_ 1818857851193393152
author Atlal El-Assaad
Zaher Dawy
Athar Khalil
Georges Nemer
author_facet Atlal El-Assaad
Zaher Dawy
Athar Khalil
Georges Nemer
author_sort Atlal El-Assaad
collection DOAJ
description Abstract Transcription factors (TFs) play important roles in many biochemical processes. Many human genetic disorders have been associated with mutations in the genes encoding these transcription factors, and so those mutations became targets for medications and drug design. In parallel, since many transcription factors act either as tumor suppressors or oncogenes, their mutations are mostly associated with cancer. In this perspective, we studied the GATA3 transcription factor when bound to DNA in a crystal structure and assessed the effect of different mutations encountered in patients with different diseases and phenotypes. We generated all missense mutants of GATA3 protein and DNA within the adjacent and the opposite GATA3:DNA complex models. We mutated every amino acid and studied the new binding of the complex after each mutation. Similarly, we did for every DNA base. We applied Poisson-Boltzmann electrostatic calculations feeding into free energy calculations. After analyzing our data, we identified amino acids and DNA bases keys for binding. Furthermore, we validated those findings against experimental genetic data. Our results are the first to propose in silico modeling for GATA:DNA bound complexes that could be used to score effects of missense mutations in other classes of transcription factors involved in common and genetic diseases.
first_indexed 2024-12-19T08:46:57Z
format Article
id doaj.art-29cec673a8804bdeae490fdb3c8d0364
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T08:46:57Z
publishDate 2021-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-29cec673a8804bdeae490fdb3c8d03642022-12-21T20:28:47ZengNature PortfolioScientific Reports2045-23222021-11-0111111510.1038/s41598-021-01832-zMutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndromeAtlal El-Assaad0Zaher Dawy1Athar Khalil2Georges Nemer3Department of Electrical and Computer Engineering, American University of Beirut (AUB)Department of Electrical and Computer Engineering, American University of Beirut (AUB)Department of Biochemistry and Molecular Genetics, American University of Beirut (AUB)Department of Biochemistry and Molecular Genetics, American University of Beirut (AUB)Abstract Transcription factors (TFs) play important roles in many biochemical processes. Many human genetic disorders have been associated with mutations in the genes encoding these transcription factors, and so those mutations became targets for medications and drug design. In parallel, since many transcription factors act either as tumor suppressors or oncogenes, their mutations are mostly associated with cancer. In this perspective, we studied the GATA3 transcription factor when bound to DNA in a crystal structure and assessed the effect of different mutations encountered in patients with different diseases and phenotypes. We generated all missense mutants of GATA3 protein and DNA within the adjacent and the opposite GATA3:DNA complex models. We mutated every amino acid and studied the new binding of the complex after each mutation. Similarly, we did for every DNA base. We applied Poisson-Boltzmann electrostatic calculations feeding into free energy calculations. After analyzing our data, we identified amino acids and DNA bases keys for binding. Furthermore, we validated those findings against experimental genetic data. Our results are the first to propose in silico modeling for GATA:DNA bound complexes that could be used to score effects of missense mutations in other classes of transcription factors involved in common and genetic diseases.https://doi.org/10.1038/s41598-021-01832-z
spellingShingle Atlal El-Assaad
Zaher Dawy
Athar Khalil
Georges Nemer
Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome
Scientific Reports
title Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome
title_full Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome
title_fullStr Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome
title_full_unstemmed Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome
title_short Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome
title_sort mutational signatures in gata3 transcription factor and its dna binding domain that stimulate breast cancer and hdr syndrome
url https://doi.org/10.1038/s41598-021-01832-z
work_keys_str_mv AT atlalelassaad mutationalsignaturesingata3transcriptionfactoranditsdnabindingdomainthatstimulatebreastcancerandhdrsyndrome
AT zaherdawy mutationalsignaturesingata3transcriptionfactoranditsdnabindingdomainthatstimulatebreastcancerandhdrsyndrome
AT atharkhalil mutationalsignaturesingata3transcriptionfactoranditsdnabindingdomainthatstimulatebreastcancerandhdrsyndrome
AT georgesnemer mutationalsignaturesingata3transcriptionfactoranditsdnabindingdomainthatstimulatebreastcancerandhdrsyndrome